Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor–positive/human epidermal growth factor receptor 2–negative metastatic breast cancer in PALOMA-3
2018 ◽
Vol 104
◽
pp. 21-31
◽
Massimo Cristofanilli
◽
Angela DeMichele
◽
Carla Giorgetti
◽
Nicholas C. Turner
◽
Dennis J. Slamon
◽
...
Georges El Hachem
◽
Andrea Gombos
◽
Ahmad Awada
P. Schmid
◽
H.S. Rugo
◽
J. Cortés
◽
P. Blum
◽
K. Crossley
◽
...
HS Rugo
◽
P Kabos
◽
MN Dickler
◽
WJ John
◽
I Smith
◽
...
2011 ◽
Vol 41
(5)
◽
pp. 593-599
◽
H. J. Chang
◽
S.-W. Han
◽
D.-Y. Oh
◽
S.-A. Im
◽
Y. K. Jeon
◽
...
Hope S. Rugo
◽
J. Thad Beck
◽
Guy Jerusalem
◽
Hans Wildiers
◽
Peter Kabos
◽
...
Gayathri Nagaraj
◽
Cynthia X. Ma
Jun Masuda
◽
Junji Tsurutani
◽
Norikazu Masuda
◽
Manabu Futamura
◽
Koji Matsumoto
◽
...
2016 ◽
Vol 32
(2)
◽
pp. 385-394
◽
Nanxin Li
◽
Yanni Hao
◽
Andrew Kageleiry
◽
Miranda Peeples
◽
Anna Fang
◽
...
2011 ◽
Vol 28
(8)
◽
pp. 603-614
◽
Close
Export Citation Format
Close
Share Document
Close